Multiplex Gene-Editing Strategy to Engineer Allogeneic EGFR-Targeting CAR T-Cells with Improved Efficacy against Solid Tumors

Scientists described a multifaceted approach to engineer allogeneic CAR T-cells resistant to both biochemical and immunological inhibitory signaling using an adenine base editor and a CRISPR-Cas12b nuclease.